UBS Group AG UBS
49.67
1.21
2.50%
as of 25 Sep
- Market cap
- $149.9B
- P/E
- 16.2×
Follow UBS
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
8.25% | 8.82% | 10.12% | 10.63% | |
| 0.45% | 0.49% | 1.18% | 0.56% | ||
ROIC |
3.20% | 0.00% | 0.00% | 3.60% | |
Return on Tangible Assets |
6.98% | 2.84% | (8.60%) | 8.18% | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.70 | 6.25 | 0.00 | 3.84 | |
Free Cash Flow |
2,215.00 | 19,698.00 | — | 11,828.00 | |
Capital Expenditures |
(2,079.00) | (2,153.00) | — | (2,700.00) | |
Piotroski F-Score |
5.00 | 6.00 | — | 6.00 | |
| Other line items | |||||
Cash ROIC |
0.63% | 2.59% | 0.00% | 2.08% | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.04 | 0.03 | 0.03 | 0.00 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | — | |
Average Days of Payables |
10,125.29 | 10,840.23 | 11,319.51 | 0.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | — | |
Tax Rate |
(0.10) | (0.12) | (0.13) | (0.20) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
48.13% | 48.86% | 48.69% | 54.49% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
0.59 | 2.81 | 0.00 | 1.53 | |
Depreciation/Fixed assets |
0.23 | 0.22 | 0.00 | 0.26 | |
Capex/Depreciation |
(0.57) | (0.61) | — | (0.64) | |
Revenue per Share |
24.58 | 24.15 | 24.76 | 22.36 | |
Operating CF per Share |
1.37 | 6.93 | 0.00 | 4.71 | |
Capex per Share |
(0.66) | (0.68) | 0.00 | (0.88) | |
Capex to Sales |
0.03 | 0.03 | 0.00 | 0.04 | |
Net Profit Margin |
9.49% | 10.20% | 11.90% | 13.80% |
Columns are period end dates